Chi Advisors LLC Global Blood Therapeutics, Inc. Transaction History

Chi Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$32.46 - $43.42 $486,900 - $651,300	-15,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $303,732 - $396,630	-7,800 Reduced 34.21%	15,000 $611,000
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $256,020 - $433,636	6,800 Added 42.5%	22,800 $987,000
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $158,280 - $223,469	3,000 Added 23.08%	16,000 $882,000
Q2 2020 Aug 12, 2020	SELL	$48.73 - $81.82 $134,007 - $225,004	-2,750 Reduced 17.46%	13,000 $821,000
Q1 2020 May 14, 2020	SELL	$41.72 - $87.2 $177,310 - $370,600	-4,250 Reduced 21.25%	15,750 $805,000
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $365,600 - $654,880	-8,000 Reduced 28.57%	20,000 $1.59 Million
Q3 2019 Nov 12, 2019	BUY	$45.35 - $57.91 $1.27 Million - $1.62 Million	28,000 New	28,000 $1.36 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Chi Advisors LLC with notifications on news.